Thyrocare Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/05/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 (1) (a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we wish to intimate that a meeting of our Board of Directors of the Company will be held on Saturday, May 8, 2021, inter alia, to consider and approve Audited Stand-alone and Consolidated Financial Results of the Company for the quarter / financial year ended March 31, 2021, to consider recommending final dividend, if any, for the financial year 2020-21, and to consider granting of Employee Stock Options for the financial year ended March 31, 2021.
|